Records 1 - 23
| Analysis of actionable genetic alterations in lung carcinoma from the VA National Precision Oncology Program.
Seminars in oncology 2022 Jul .
Jalal Shadia I, Guo Aixia, Ahmed Sara, Kelley Michael
| Clinicopathological Impact of the Spread through Air Space in Non-Small Cell Lung Cancer: A Meta-Analysis.
Diagnostics (Basel, Switzerland) 2022 Apr 12 (5): .
Pyo Jung-Soo, Kim Nae
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype.
Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142.
Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi
| Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics.
PloS one 2022 17 (1): e0262822.
Li Fanghua, Ye Peng, Cai Peiling, Dong Dandan, Zhang Yihao, Yang Yue, Sun Xingwa
| NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis.
International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e421.
Li X, Yu J, Wang
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China.
Frontiers in oncology 2021 11 630717.
Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe
| The landscape of kinase domain duplication in Chinese lung cancer patients.
Annals of translational medicine 2020 Dec 8 (24): 1642.
Wu Di, Xie Yuancai, Jin Chang'e, Qiu Jinfan, Hou Ting, Du Haiwei, Chen Songan, Xiang Jianxing, Shi Xi, Liu Junli
| EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell lung cancer in South India.
Cancer reports (Hoboken, N.J.) 2020 Sep e1288.
Tarigopula Anil, Ramasubban Gayathri, Chandrashekar Vani, Govindasami Perumal, Chandran Chit
| Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Clinical lung cancer 2020 Feb .
Zhao Yiming, Dong Yu, Zhao Ruiying, Zhang Bo, Wang Shuyuan, Zhang Lele, Hu Minjuan, He Qingnan, Zhang Wei, Han Baoh
| Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis.
Journal of thoracic disease 2019 Jul 11 (7): 2965-2972.
Masuda Ken, Fujiwara Yutaka, Shinno Yuki, Mizuno Takaaki, Sato Jun, Morita Ryo, Matsumoto Yuji, Murakami Shuji, Goto Yasushi, Kanda Shintaro, Horinouchi Hidehito, Yamamoto Noboru, Ohe Yuichi
| Prevalence of MET exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute study.
Journal of cancer research and therapeutics 2019 15 (4): 909-913.
Yu Yongfeng, Zhang Qing, Zhang Jie, Lu Sh
| Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2018 Feb .
Pan X, Lv T, Zhang F, Fan H, Liu H, Song
| Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
Lung cancer (Amsterdam, Netherlands) 2018 02 116 30-37.
Zhou Fei, Hou Likun, Ding Ting, Song Quanming, Chen Xiaoxia, Su Chunxia, Li Wei, Gao Guanghui, Ren Shengxiang, Wu Fengying, Fan Jiang, Wu Chunyan, Zhang Jie, Zhou Caic
| [Clinical significance and mechanism of upregulation of PI3Kp110a in non-small cell lung carcinoma].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2017 Oct 39 (10): 737-743.
Xiong Y, Qu L L, Li D, Wang Y, Li
| Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.
Oncotarget 2017 Aug 8 (35): 59113-59122.
Nakagaki Takafumi, Tamura Miyuki, Kobashi Kenta, Koyama Ryota, Fukushima Hisayo, Ohashi Tomoko, Idogawa Masashi, Ogi Kazuhiro, Hiratsuka Hiroyoshi, Tokino Takashi, Sasaki Yasus
| A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population.
Lung cancer (Amsterdam, Netherlands) 2017 Jan 103 82-89.
Gow Chien-Hung, Hsieh Min-Shu, Wu Shang-Gin, Shih Jin-Yu
| Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Apr .
Schneider Frank, Derrick Veronica, Davison Jon M, Strollo Diane, Incharoen Pimpin, Dacic San
| Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
Cancer cytopathology 2016 Mar .
Allison Derek B, Lilo Mohammed T, Geddes Susan, Pallavajjalla Aparna, Askin Frederic, Gabrielson Edward, Zheng Gang, Li Qing K
| The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations.
OncoTargets and therapy 2016 9 833-43.
Zheng Difan, Wang Rui, Zhang Yang, Pan Yunjian, Cheng Xinghua, Cheng Chao, Zheng Shanbo, Li Hang, Gong Ranxia, Li Yuan, Shen Xuxia, Sun Yihua, Chen Haiqu
| Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients.
Oncotarget 2015 Oct .
Wang Rui, Zhang Yang, Pan Yunjian, Li Yuan, Hu Haichuan, Cai Deng, Li Hang, Ye Ting, Luo Xiaoyang, Zhang Yiliang, Li Bin, Shen Lei, Sun Yihua, Chen Haiqu
| Genetic profiling of thymic carcinoma using targeted next-generation sequencing.
Lung cancer (Amsterdam, Netherlands) 2014 Nov 86 (2): 174-9.
Shitara Masayuki, Okuda Katsuhiro, Suzuki Ayumi, Tatematsu Tsutomu, Hikosaka Yu, Moriyama Satoru, Sasaki Hidefumi, Fujii Yoshitaka, Yano Moto
| Multiplex genomic profiling of non-small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study.
Oncotarget 2014 Apr 5 (8): 2293-304.
Okamoto Isamu, Sakai Kazuko, Morita Satoshi, Yoshioka Hiroshige, Kaneda Hiroyasu, Takeda Koji, Hirashima Tomonori, Kogure Yoshihito, Kimura Tatsuo, Takahashi Toshiaki, Atagi Shinji, Seto Takashi, Sawa Toshiyuki, Yamamoto Masashi, Satouchi Miyako, Okuno Motoyasu, Nagase Seisuke, Takayama Koichi, Tomii Keisuke, Maeda Tadashi, Oizumi Satoshi, Fujii Shinji, Akashi Yusaku, Nishino Kazumi, Ebi Noriyuki, Nakagawa Kazuhiko, Nakanishi Yoichi, Nishio Kazu
| Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays.
BMC cancer 2014 14 786.
Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Toshiaki, Taira Tetsuhiko, Ono Akira, Maniwa Tomohiro, Takahashi Shoji, Mori Keita, Endo Masahiro, Abe Masato, Hayashi Isamu, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu